Clinical trial
Q702 for the Treatment of Patients With Hematologic Malignancies
NCT06712810
Study timeline
Study start (actual)2025-08-27Date precision: day
Registry last updated2025-10-10
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Histiocytic Sarcomaunresolved
Malignant Histiocytosisunresolved
Recurrent Chronic Lymphocytic Leukemiaunresolved
Recurrent Follicular Lymphomaunresolved
Recurrent Langerhans Cell Histiocytosisunresolved
Recurrent Lymphoplasmacytic Lymphomaunresolved
Recurrent Myelodysplastic Syndromeunresolved
Recurrent Myelofibrosisunresolved
Recurrent Small Lymphocytic Lymphomaunresolved
Recurrent Waldenstrom Macroglobulinemiaunresolved
Refractory Chronic Lymphocytic Leukemiaunresolved
Refractory Erdheim-Chester Diseaseunresolved
Refractory Follicular Lymphomaunresolved
Refractory Langerhans Cell Histiocytosisunresolved
Refractory Lymphoplasmacytic Lymphomaunresolved
Refractory Myelodysplastic Syndromeunresolved
Refractory Myelofibrosisunresolved
Refractory Small Lymphocytic Lymphomaunresolved
Refractory Waldenstrom Macroglobulinemiaunresolved
Rosai-Dorfman-Destombes Diseaseunresolved
Primary Central Nervous System Lymphomaunresolved
Recurrent Erdheim-Chester Diseaseunresolved
Recurrent Histiocytic Sarcomaunresolved
Refractory Histiocytic Sarcomaunresolved
Interventions
Biospecimen CollectionPROCEDURE
Bone Marrow AspirationPROCEDURE
Bone Marrow BiopsyPROCEDURE
Computed TomographyPROCEDURE
Magnetic Resonance ImagingPROCEDURE
Positron Emission TomographyPROCEDURE
Sponsors & collaborators
Mayo Cliniclead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06712810 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.